Eli Lilly, EQT, Cash Cows ETF, Northrop Grumman And This Diagnostics Company Feature On CNBC's Final Trad

On CNBC’s “Halftime Report Final Trades,” Bryn Talkington of Requisite Capital Management said Pacer US Cash Cows 100 ETF (BATS:COWZ) is “a factor-based ETF that screens for the 100 highest free cash flow yielding companies in the S&P.” The two biggest sectors are energy and healthcare, Talkington mentioned. “It has a free cash flow yield of 12.5%, a PE of 6.5% and a dividend of 2.5%,” she added.

Shannon Saccocia of Boston Private said Quest Diagnostics Inc. (NYSE:DGX) has 4% to 5% revenue growth and 7% to 9% EPS growth and is a defensive play.

Check out other stocks making moves in the premarket.

Rob Sechan of New Edge Capital Group mentioned that Eli Lilly And Co’s (NYSE:LLY) Alzheimer’s drug “is great too.”

Also Read: Is Tesla Making A Mistake Building Optimus To Resemble A Human? Ark Analyst And Elon Musk Weigh In

Stephen Weiss of Short Hills Capital Partners said that although EQT Corporation (NYSE:EQT) had declined last week, “I think they’ll come back to natgas stocks.”

Joseph Terranova of Virtus Investment Partners chose Northrop Grumman Corporation (NYSE:NOC) as his final trade.